Figure 1.
Figure 1. Upstream events in BCR signaling. (A) BCR signaling in the absence of antigen binding provides a tonic survival signal dependent on PI3K. In this model, the Ras GTPAse TC21 binds to nonphosphorylated tyrosine motifs (black boxes) in Igα and Igβ and activates PI3K-dependent survival signals. PI3Kα and PI3Kδ assume redundant functions in this pathway. (B) BCR signaling in response to antigen binding induces LYN- and SYK-dependent phosphorylation (phosphorylation denoted by “P” in orange circle) of tyrosine motifs (red boxes) on CD79A and CD79B. A number of protein kinases (red symbols) and the lipid kinase PI3Kδ (blue symbol) transmit survival, cell growth, and proliferation signals and regulate cell migration. The transcription factors NF-κB and NFAT are important regulators of BCR-induced gene expression changes. Small-molecule inhibitors of select kinases in the BCR pathway that have demonstrated significant clinical activity are indicated.

Upstream events in BCR signaling. (A) BCR signaling in the absence of antigen binding provides a tonic survival signal dependent on PI3K. In this model, the Ras GTPAse TC21 binds to nonphosphorylated tyrosine motifs (black boxes) in Igα and Igβ and activates PI3K-dependent survival signals. PI3Kα and PI3Kδ assume redundant functions in this pathway. (B) BCR signaling in response to antigen binding induces LYN- and SYK-dependent phosphorylation (phosphorylation denoted by “P” in orange circle) of tyrosine motifs (red boxes) on CD79A and CD79B. A number of protein kinases (red symbols) and the lipid kinase PI3Kδ (blue symbol) transmit survival, cell growth, and proliferation signals and regulate cell migration. The transcription factors NF-κB and NFAT are important regulators of BCR-induced gene expression changes. Small-molecule inhibitors of select kinases in the BCR pathway that have demonstrated significant clinical activity are indicated.

Close Modal

or Create an Account

Close Modal
Close Modal